$400,000 award will support characterization and efficacy testing of preclinical SR-03 cell line as a part of IND development. Seraxis is taking meetings at the American Diabetes Association Annual Meeting in Orlando, June 21-24.
Read Press ReleaseRenova is exploring new therapeutic opportunities that have the potential to expand the use of Renova’s gene therapy platform to include several pathologies associated with diabetes and heart failure.
Read Press ReleasePartnership addresses biopharmaceutical industry’s urgent need for improved in-process and QC testing tools for these rapidly evolving application fields
Read Press ReleasePharmaNest, a leader in high-resolution, single-fiber quantitative Digital Pathology and Artificial Intelligence, showcases the performance of its FibroNest Ph-FCS digital biomarker for quantifying fibrosis severity and its clinical utility in Phase 2 and Phase 3 studies for patients with Metabolic Associated Steatohepatitis (MASH).
Read Press ReleaseRenowned Nephrologist and Researcher Will Support Panoramic Health’s Efforts to Redefine the Standard of Kidney Care Through Novel Therapies
Read Press ReleaseDigital tool gives real-time feedback on the impact of changes to clinical study protocols, helping clinical teams reduce the cost, duration and burden of studies on sponsors, sites and patients.
Read Press ReleaseValidated, off-the-shelf kit for multiplexed seasonal hemagglutinin (HA) detection and quantification addresses the unique challenges faced by vaccine developers and manufacturers.
Read Press ReleaseThis represents a monumental advancement for the hemp industry — a comprehensive processing solution from biomass input to T-free crude and/or distillate. This pioneering breakthrough addresses the challenge of processing 'hot' oil with noncompliant THC content, seamlessly processing to a T-free end product. This capability is also indispensable for facilities aspiring to operate under pharmaceutical and Good Manufacturing Practice (GMP) standards.
Read Press ReleaseAs federal and state governments implement far-ranging programs to address the crisis, PillSafe offers a technology-based solution that ensures patients comply with prescriptions.
Read Press ReleaseRenova Has Prioritized Two Primary Regulatory Pathways Where It Is Poised to Launch Pivotal Human Trials for Its Promising Gene Therapies to Treat Heart Failure and Type 2 Diabetes Mellitus
Read Press ReleaseNew Capabilities Empower Gene Therapy Developers to Explore a Broader Range of Vector Designs and Rapidly Identify Candidates Best Poised for IND Speed and Success
Read Press ReleasePresentations Focused on How AI is Leveraged to Optimize Gene Therapy Construct Designs for Safety, Yield and Efficacy — Resulting in Faster Delivery to Market With a Higher Probability of Success
Read Press ReleaseBringing Together the Top Minds Across Vector Engineering, Viral Vector Delivery Systems and Next-Generation Gene Transfer Technologies Further Cements Form Bio’s Position as a Leader in AI-Driven Cell and Gene Therapy
Read Press ReleaseFishawack Health Founder's Deep History in Healthcare Communications Blends Nicely with Global Scientific Communications Agency's Upcoming Buy-and-Build Strategy
Read Press Release